NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 58 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $19,946,000 | +34.2% | 14,932,000 | +39.7% | 0.02% | +21.1% |
| Q4 2020 | $14,858,000 | -1.3% | 10,691,000 | +18.8% | 0.02% | -17.4% |
| Q2 2020 | $15,054,000 | -45.6% | 9,000,000 | -58.1% | 0.02% | -54.9% |
| Q1 2020 | $27,660,000 | -10.0% | 21,500,000 | +7.5% | 0.05% | +15.9% |
| Q4 2019 | $30,725,000 | +27.7% | 20,000,000 | +14.1% | 0.04% | +10.0% |
| Q3 2019 | $24,052,000 | +4.4% | 17,535,000 | +0.2% | 0.04% | +8.1% |
| Q2 2019 | $23,047,000 | +15.4% | 17,500,000 | +18.6% | 0.04% | +12.1% |
| Q1 2019 | $19,969,000 | +33.6% | 14,750,000 | +18.0% | 0.03% | +17.9% |
| Q4 2018 | $14,952,000 | +25.1% | 12,500,000 | +78.6% | 0.03% | +47.4% |
| Q3 2018 | $11,949,000 | +65.3% | 7,000,000 | +40.0% | 0.02% | +46.2% |
| Q2 2018 | $7,228,000 | – | 5,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 45,447,000 | $60,497,000 | 1.31% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,366,000 | $5,924,000 | 0.54% |
| Aequim Alternative Investments LP | 7,609,000 | $10,088,000 | 0.43% |
| MACKAY SHIELDS LLC | 27,806,000 | $37,405,000 | 0.35% |
| Weiss Asset Management LP | 10,000,000 | $13,290,000 | 0.33% |
| WOLVERINE ASSET MANAGEMENT LLC | 13,230,000 | $17,541,000 | 0.13% |
| Polar Asset Management Partners Inc. | 7,500,000 | $9,942,000 | 0.10% |
| LORD, ABBETT & CO. LLC | 22,141,000 | $29,732,000 | 0.07% |
| Calamos Advisors LLC | 7,500,000 | $9,967,000 | 0.05% |
| D. E. Shaw & Co., Inc. | 39,270,000 | $52,046,000 | 0.04% |